InvestorsHub Logo
Followers 8
Posts 443
Boards Moderated 0
Alias Born 03/25/2016

Re: None

Friday, 03/12/2021 8:30:43 AM

Friday, March 12, 2021 8:30:43 AM

Post# of 232957
As I see the situation:

1. CYDY management is largely incompetent and blew the CD12 Trial Design.

2. That said, shareholders should review the public statements and research of Dr. Bruce Patterson. Dr. Patterson is a brilliant Virologist and, in spite of being poorly treated by Cytodyn, is a proponent of the validity of the science underlying LL MOA. I have heard him state and extol the drug's remarkable efficacy and potential.

3. So, regardless of current management's mishandling of a truly amazing opportunity, I believe that eventually the BOD, to secure regulatory approval, will have to bring in new management and/or secure an association with a strong biopharma company.

4. My perspective is based on six years as a shareholder and intense DD, as well as personal communication with some of the principal players. Still, IMHO CYDY is a reasonably good long term investment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News